Pharmacogenomic data guidance: Industry objects to reporting exploratory studies
Regulatory NewsMary Ellen Schneider
Biologics/ biosimilars/ vaccinesClinical TrialsNorth AmericaPharmaceuticalsPreclinical studyRegulatory NewsMary Ellen SchneiderBiologics/ biosimilars/ vaccinesClinical TrialsNorth AmericaPharmaceuticalsPreclinical study